Approval · Notice of Compliance 2986 · 1998
WELLFERON: Notice of Compliance 2986
Issued June 8, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2986
- Date
- June 8, 1998
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication - chronic hepatitis c infection plus additional revisions to the product monograph
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WELLFERON | Not yet assigned | — |
Medicinal ingredients
- HUMAN LYMPHOBLASTOID INTERFERON 3 UNIT per ML
- HUMAN LYMPHOBLASTOID INTERFERON 5 UNIT per ML
- HUMAN LYMPHOBLASTOID INTERFERON 10 UNIT per ML